【参考文献】
  1 Sharma JN. Does the kinin system mediate in cardiovascular abnormalities? An overview. J Clin Pharmacol ,2003;43(11):1187-1195

2 Ma JX, Song Q, Hatcher HC, Crouch RK, Chao L, Chao J. Expression and cellular localization of the kallikrein-kinin system in human ocular tissues. Exp Eye Res ,1996;63(1):19-26

3 Kohner EM. Diabetic retinopathy. BMJ ,1993;307(6913):1195-1199

4 Yayama K, Nagaoka M, Takano M, Okamoto H. Expression of kininogen, kallikrein and kinin receptor genes by rat cardiomyocytes. Biochim Biophys Acta ,2000;1495(1):69-77

5 Chao J, Stallone JN, Liang YM, Chen LM, Wang DZ, Chao L. Kallistatin is a potent new vasodilator. J Clin Invest ,1997;100(1):11-17

6 Gao G, Shao C, Zhang SX, Dudley A, Fant J, Ma JX. Kallikrein-binding protein inhibits retinal neovascularization and decreases vascular leakage. Diabetologia ,2003;46(5):689-698

7 Patacchini R, Maggi CA. Peripheral tachykinin receptors as targets for new drugs. Eur J Pharmacol ,2001;429(1-3):13-21

8 Farmer SG, DeSiato MA. Effects of a novel nonpeptide bradykinin B2 receptor antagonist on intestinal and airway smooth muscle: further evidence for the tracheal B3 receptor. Br J Pharmacol ,1994;112(2):461-464

9 Saha JK, Sengupta JN, Goyal RK. Effect of bradykinin on opossum esophageal longitudinal smooth muscle: evidence for novel bradykinin receptors. J Pharmacol Exp Ther ,1990;252(3):1012-1020

10 Saha JK, Sengupta JN, Goyal RK. Effects of bradykinin and bradykinin analogs on the opossum lower esophageal sphincter: characterization of an inhibitory bradykinin receptor. J Pharmacol Exp Ther ,1991;259(1):265-273

11 Ignarro LJ, Byrns RE, Buga GM, Wood KS. Mechanisms of endothelium-dependent vascular smooth muscle relaxation elicited by bradykinin and VIP. Am J Physiol ,1987;253(5Pt2):1074-1082

12 Kichuk MR, Seyedi N, Zhang X, Marboe CC, Michler RE, Addonizio LJ, Kaley G, Nasjletti A, Hintze TH. Regulation of nitric oxide production in human coronary microvessels and the contribution of local kinin formation. Circulation ,1996;94(1):44-51

13 Siragy HM, Jaffa AA, Margolius HS. Bradykinin B2 receptor modulates renal prostaglandin E2 and nitric oxide. Hypertension ,1997;29(3):757-762

14 Greene EL, Velarde V, Jaffa AA. Role of reactive oxygen species in bradykinin-induced mitogen-activated protein kinase and c-fos induction in vascular cells. Hypertension ,2000;35(4):942-947

15 Morbidelli L, Parenti A, Giovannelli L, Granger HJ, Ledda F, ZicheM. B1 receptor involvement in the effect of bradykinin on venular endothelial cell proliferation and potentiation of FGF-2 effects. Br J Pharmacol ,1998;124(6):1286-1292

16 Hayashi I, Amano H, Yoshida S, Kamata K, Kamata M, Inukai M, Fujita T, Kumagai Y, Furudate S, Majima M. Suppressed angiogenesis in kininogen-deficiencies. Lab Invest ,2002;82(7):871-880

上一页  [1] [2] [3] [4] [5] [6] 下一页